Given that the remaining full-length (FL) SMN2 (SMN2) transcripts can compensate for the SMN1 defect to a limited extent, the severity of the clinical expression of SMA is mitigated by the number of SMN2 copies [7]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.